News

• March 10, 2006
  

  FDA Release: The Predictive Safety Testing Consortium

  The Food and Drug Administration (FDA) and The Critical Path Institute (C-Path) today announced the formation of the Predictive Safety Testing Consortium between C-Path and five of America’s largest pharmaceutical companies to share internally developed laboratory methods to predict the safety of new treatments before they are tested in humans.
• March 10, 2006
  

  C-Path Forms Drug Testing Pact

  The Tucson-based Critical Path Institute on Thursday announced an unprecedented agreement with eight major pharmaceutical companies to share drug-testing methods in an effort to improve drug safety.
• February 10, 2006
  

  Drug Research Institute Sdds Liason From UA

  The retired head of research at the University of Arizona has joined the Tucson-based Critical Path Institute, a UA- and FDA-affiliated drug research institute, as head of its affiliations with research universities.
• January 10, 2006
  

  C-Path to Spur Medical Innovation

  We all remember the Vioxx scare and authorities say it could happen again. However, the FDA is stepping up its efforts to improve the safety of prescription drugs and here in Tucson a research group is piloting a program to examine and detect them carefully.